Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Johnson & Johnson

Procter & Gamble

The S&P 500 is doing great this year after last year's historic run higher. The broad index is up almost 9% in 2024.

The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash

Archer-Daniels-Midland Company

American States Water

Black Hills

California Water Service Group

Federal Realty Investment Trust

Fortis

Hormel Foods

Coca-Cola

Kenvue

Leggett & Platt

Middlesex Water

National Fuel Gas

Northwest Natural Gas

SJW Group

United Bankshares

Universal Corp

"What is a Dividend King? A stock with 50 or more consecutive years of dividend increases."—suredividend.com. The 55 Dividend Kings screened as of April 10 represented 9 of 11 Morningstar Sectors. Broker targeted-top-ten net-gains ranged 15.19%-33.38% topped-by Middlesex Water, and SJW Group. By yield, Leggett tops-all. Top-ten April Kings: FRT, UBSI, FTS, BKH, NWN, CDUAF, MMM, UVV, MO, & LEG averaged 6.24% in yield.

55 April Dividend Kings: Buy 8, Watch 8

Air Products and Chemicals

Community Bank System

Cullen/Frost Bankers

C.H. Robinson Worldwide

NextEra Energy

Polaris

Dividend aristocrats have underperformed due to an overweight in utilities, but recent trends suggest a potential rally.

10 Dividend Aristocrat Bargain Buys Yielding As Much As 9.4%

Pfizer

Dividend stocks generally don't offer high yields unless there are concerns about their ability to grow earnings. The rapid loss of COVID-19 product revenue makes Pfizer seem so risky that it offers a 6.3% yield at recent prices.

2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA TO HOST WEBCAST OF 2024 FIRST-QUARTER RESULTS.

Altria to Host Webcast of 2024 First-Quarter Results

British American Tobacco

JPMorgan Nasdaq Equity Premium Income ETF

Reaves Utility Income Fund

Verizon

Minneapolis Federal Reserve Bank President's comments spooked markets, but they rebounded by the end of the week.

Dividend Harvesting Portfolio Week 162: $16,200 Allocated, $1,450.45 In Projected Dividends

Altria has failed to find other sources of revenue to offset drops in tobacco usage. The company generates enough net income to support its massive dividend (for now).

Is the Business Model of Altria Stock Finally About to Break?

Altria owns the rights to Philip Morris cigarette brands in the United States. British American Tobacco has a global portfolio of cigarette brands.

Best Stock to Buy Right Now: Altria vs British American Tobacco

Altria (MO) benefits from its focus on smoke-free product expansion and pricing power amid low cigarette volumes.

Altria's (MO) Smoke-Free Strength Helps Navigate Challenges

Energy Transfer LP Unit

With the S&P 500 yielding less than 2% on average right now, high dividend stocks are hard to find. Even though interest rates have risen significantly over the past few years, the major equity indices are broadly unappealing for income investors.

3 High-Yield Dividend Stocks to Buy With Payouts Over 8%

Finding a qualified financial advisor doesn't have to be hard. SmartAsset's free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes.

3 Magnificent Dividend Stocks Great For Retirement Accounts

Ares Capital

Berry Petroleum Corp.

Gladstone Capital

Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In other words, the total return on an investment or portfolio consists of income and stock appreciation.

5 Absolutely Best Dividend Stocks Yielding Over 9%

AbbVie

Morgan Stanley

PepsiCo

Philip Morris

Exxon Mobil

The topic of passive income is popular these days. Investors, consumers, and many other individuals are curious about any method that can produce income without work.

Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year

Altria's dividend yield is roughly 9% today, a huge figure compared to the broader market. The company's most important business is crumbling.

Altria's 9% Dividend Yield Isn't the Most Important Investment Factor. This Is the One Investors Should Watch

Anheuser-Busch InBev

This off-the-radar utility stock suits worried conservative investors and pays a solid 5.32% dividend.

Passive Income Investors Love These 5 Dividend Kings and One Pays 9%

Altria has a 9% forward dividend yield and is diversifying its product portfolio to address the declining number of conventional cigarette smokers. The company has a strong position in the U.S. e-cigarette/vape market and the nicotine pouches market, both of which are expected to experience significant growth. There are potential risks, such as an ongoing patent fight and the increasing health consciousness of consumers, but overall, Altria's dividend yield and upside potential make it a "Strong Buy.".

Altria: Stellar Flexibility And Resilience

AT&T

Dividend stocks generally don't offer high yields unless investors have reasons to be nervous about profit growth. Combustible cigarette sales are declining so rapidly that Altria Group offers a 9.0% dividend yield.

2 Beaten-Down Dividend Stocks With Yields Above 6% to Buy Now and Hold Forever

SPDR S&P 500 ETF Trust

Ford Motor Company

The first quarter of the year was a success for investors. The overall market NYSE: SPY surged nearly 10%, fueled by robust economic indicators, optimism, and hype surrounding AI.

4 Dividend Aristocrats Trading at a Discount

Annaly Capital

Seagate Technology Holdings PLC

Valero Energy

We've found five stocks that pay yields of around 6% or more and that appear to be capable of maintaining those yields for the next 12 months.

Sky-High Dividend Stocks With Massive Upside

6 Of The Highest Yielding Dividend Kings to Buy and Hold Forever

Medical Properties Trust

Altria's business still looks strong as it transitions more to smoke-free products. Medical Properties Trust is strengthening its financial position by pursuing asset sales, which could add $2 billion in liquidity this year.

Altria Stock vs. Medical Properties Trust: Which High-Yielding Dividend Is the Safer Option for Investors?

Altria just announced that it was raising cash by selling a portion of its stake in Anheuser-Busch InBev. Following the sale of Anheuser-Busch InBev shares, the company initiated a large stock buyback.

There's 1 Stock I Wouldn't Touch With a 10-Foot Pole. Here's Why.

BlackRock Science & Technology

Neos Nasdaq-100 High Income ETF

SL Green Realty

Neos S&P 500 High Income ETF

Fed Chair Powell delivers dovish message, predicts 3 rate cuts in 2024. Dividend Harvesting Portfolio reaches record profitability and balance.

Dividend Harvesting Portfolio Week 160: $16,000 Allocated, $1,420.50 In Projected Dividends

News for Altria Stock (MO)